PUMA BIOTECHNOLOGY, INC.

PBYI · Nasdaq · SIC 2834: Pharmaceutical Preparations
277
SEC Filings

Business Summary

PART I Company Overview Unless otherwise provided in this Annual Report, references to the Company, we, us, and our refer to Puma Biotechnology, Inc. and our wholly owned subsidiary. We are a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. We are currently commercializing NERLYNX, an oral version of neratinib, for the treatment ofcertain HER2-positivebreast cancers.Additionally, we have in-licensed...

Next Earnings

Q2 FY2026 — expected 2026-08-14

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionPBYIdiscussed_in_filing Cybersecurity
topic_mentionPBYIdiscussed_in_filing Trusted Computing
topic_mentionPBYIdiscussed_in_filing Blockchain & Crypto
topic_mentionPBYIdiscussed_in_filing Regulation
topic_mentionPBYIdiscussed_in_filing Healthcare & Bio
topic_mentionPBYIdiscussed_in_filing Cybersecurity
topic_mentionPBYIdiscussed_in_filing Trusted Computing
topic_mentionPBYIdiscussed_in_filing Blockchain & Crypto
topic_mentionPBYIdiscussed_in_filing Regulation
topic_mentionPBYIdiscussed_in_filing Healthcare & Bio
topic_mentionPBYIdiscussed_in_filing Cybersecurity
topic_mentionPBYIdiscussed_in_filing Trusted Computing
topic_mentionPBYIdiscussed_in_filing Blockchain & Crypto
topic_mentionPBYIdiscussed_in_filing Regulation
topic_mentionPBYIdiscussed_in_filing Healthcare & Bio
topic_mentionPBYIdiscussed_in_filing Cybersecurity
topic_mentionPBYIdiscussed_in_filing Trusted Computing
topic_mentionPBYIdiscussed_in_filing Blockchain & Crypto
topic_mentionPBYIdiscussed_in_filing Regulation
topic_mentionPBYIdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001437749-26-005891EDGAR108K words
2025-02-272024-12-310001437749-25-005496EDGAR—
2024-02-292023-12-310001437749-24-006121EDGAR—
2023-03-022022-12-310001437749-23-005233EDGAR—
2022-03-032021-12-310001437749-22-005164EDGAR—
2021-03-012020-12-310001564590-21-009840EDGAR—
2020-02-282019-12-310001564590-20-007591EDGAR—
2019-03-012018-12-310001564590-19-005830EDGAR—
2018-03-092017-12-310001564590-18-005152EDGAR—
2017-03-012016-12-310001564590-17-003090EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001437749-25-033633EDGAR36K words
2025-08-072025-06-300001437749-25-025470EDGAR—
2025-05-082025-03-310001437749-25-015533EDGAR—
2024-11-072024-09-300001437749-24-033955EDGAR—
2024-08-012024-06-300001437749-24-024309EDGAR—
2024-05-022024-03-310001437749-24-014395EDGAR—
2023-11-022023-09-300001437749-23-030028EDGAR—
2023-08-032023-06-300001437749-23-021972EDGAR—
2023-05-042023-03-310001437749-23-012589EDGAR—
2022-11-032022-09-300001437749-22-025787EDGAR—
2022-08-042022-06-300001437749-22-018920EDGAR—
2022-05-052022-03-310001437749-22-011142EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-260001437749-26-005869EDGAR4K words
2025-11-060001437749-25-033604EDGAR—
2025-08-070001437749-25-025463EDGAR—
2025-06-240001437749-25-021153EDGAR—
2025-06-130001437749-25-020321EDGAR—
2025-05-090001437749-25-015648EDGAR—
2025-05-080001437749-25-015514EDGAR—
2025-02-270001437749-25-005477EDGAR—
2024-11-070001437749-24-033929EDGAR—
2024-09-160001437749-24-029206EDGAR—

277 total filings indexed. 245 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001401667
TickerPBYI
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 36e9ee109b3c614245b175d67c85ad958f6d4f76824bf86cdfffc8de8afc2511
parent: 7c266af5709fb34f1593769d89941d169f1e41ebdca60ae113584e566f3cd843
content hash: ec8b3bf05750fd7e73b6f4a2f97edfc82e3e3d323ce3001de0e297579a634852
signed: 2026-04-13T04:46:49.948Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf